|
Name |
2,5-Dihydroxybenzaldehyde
|
Molecular Formula | C7H6O3 | |
IUPAC Name* |
2,5-dihydroxybenzaldehyde
|
|
SMILES |
C1=CC(=C(C=C1O)C=O)O
|
|
InChI |
InChI=1S/C7H6O3/c8-4-5-3-6(9)1-2-7(5)10/h1-4,9-10H
|
|
InChIKey |
CLFRCXCBWIQVRN-UHFFFAOYSA-N
|
|
Synonyms |
2,5-Dihydroxybenzaldehyde; 1194-98-5; Gentisaldehyde; Benzaldehyde, 2,5-dihydroxy-; Gentisate aldehyde; MFCD00003333; CHEBI:28508; 2,5-dihydroxy-benzaldehyde; 0Q83HDS90W; CHEMBL243186; NSC-72387; UNII-0Q83HDS90W; Gentisinaldehyde; EINECS 214-789-6; NSC 72387; 5-hydroxysalicylaldehyde; FORMYLHYDROQUINONE; 2,5 dihydroxybenzaldehyde; Benzaldehyde,5-dihydroxy-; bmse000962; 2,5-dihydroxy benzaldehyde; 2,5-DHBAOP; NCIOpen2_000629; SCHEMBL36835; AMY432; DTXSID1061601; 2,5-Dihydroxybenzaldehyde, 98%; ZINC895809; BCP26028; HY-N1673; NSC72387; DIHYDROXYBENZALDEHYDE, 2,5-; BDBM50478478; AKOS000112412; PS-4073; AC-12258; SY011437; DB-020084; CS-0017335; D0565; FT-0610381; EN300-49273; C05585; H11349; 194D985; A892551; J-200040; Q27103744; Z586251264; 2,5-Dihydroxybenzaldehyde, Vetec(TM) reagent grade, 98%; Benzaldehyde, 2,5-dihydroxy-;Gentisaldehyde;Gentisate aldehyde; 4991335E-F710-4A4F-927E-62D82076133E
|
|
CAS | 1194-98-5 | |
PubChem CID | 70949 | |
ChEMBL ID | CHEMBL243186 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 138.12 | ALogp: | 1.2 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 57.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.454 |
Caco-2 Permeability: | -4.599 | MDCK Permeability: | 0.00000854 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.944 |
30% Bioavailability (F30%): | 0.965 |
Blood-Brain-Barrier Penetration (BBB): | 0.087 | Plasma Protein Binding (PPB): | 65.18% |
Volume Distribution (VD): | 0.84 | Fu: | 35.68% |
CYP1A2-inhibitor: | 0.515 | CYP1A2-substrate: | 0.115 |
CYP2C19-inhibitor: | 0.068 | CYP2C19-substrate: | 0.062 |
CYP2C9-inhibitor: | 0.051 | CYP2C9-substrate: | 0.891 |
CYP2D6-inhibitor: | 0.055 | CYP2D6-substrate: | 0.608 |
CYP3A4-inhibitor: | 0.153 | CYP3A4-substrate: | 0.15 |
Clearance (CL): | 13.148 | Half-life (T1/2): | 0.91 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.041 |
Drug-inuced Liver Injury (DILI): | 0.034 | AMES Toxicity: | 0.261 |
Rat Oral Acute Toxicity: | 0.062 | Maximum Recommended Daily Dose: | 0.276 |
Skin Sensitization: | 0.81 | Carcinogencity: | 0.249 |
Eye Corrosion: | 0.976 | Eye Irritation: | 0.985 |
Respiratory Toxicity: | 0.95 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000097 | 0.514 | D0E9CD | 0.390 | ||||
ENC000344 | 0.514 | D0V9EN | 0.378 | ||||
ENC000985 | 0.500 | D0C4YC | 0.366 | ||||
ENC000166 | 0.486 | D0YF3X | 0.365 | ||||
ENC002913 | 0.476 | D03UOT | 0.361 | ||||
ENC000069 | 0.474 | D0T7OW | 0.357 | ||||
ENC000500 | 0.450 | D07MOX | 0.341 | ||||
ENC003688 | 0.429 | D08HVR | 0.333 | ||||
ENC000068 | 0.425 | D01WJL | 0.333 | ||||
ENC002464 | 0.422 | D0BA6T | 0.320 |